Phenylephrine hydrochloride and Meloxicam drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Phenylephrine hydrochloride (phenylephrine hydrochloride) and Meloxicam (meloxicam). Common drug interactions include pericarditis among females and abscess limb among males.

The phase IV clinical study analyzes what interactions people have when they take Phenylephrine hydrochloride and Meloxicam. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.

What is Phenylephrine hydrochloride?

Phenylephrine hydrochloride has active ingredients of phenylephrine hydrochloride. eHealthMe is studying from 1,240 Phenylephrine hydrochloride users. Check the latest studies of Phenylephrine hydrochloride.

What is Meloxicam?

Meloxicam has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 68,016 Meloxicam users. Check the latest studies of Meloxicam.



On Jul, 08, 2026

43 people who take Phenylephrine hydrochloride and Meloxicam together, and have interactions are studied.

Phenylephrine hydrochloride and Meloxicam drug interactions.

What are the common drug interactions of Phenylephrine Hydrochloride and Meloxicam, by gender? *:

female:

  1. Pericarditis (inflammation of the pericardium)
  2. Photophobia (extreme sensitivity to light)
  3. Pleuritic pain
  4. Pulmonary toxicity (side effects on the lungs)
  5. Maternal exposure during pregnancy (use of substance during pregnancy)
  6. Arthralgia (joint pain)
  7. Dizziness
  8. Peripheral swelling
  9. Nausea (feeling of having an urge to vomit)
  10. Joint range of motion decreased (disease of joint movement)

male:

  1. Abscess limb (limb infection)
  2. Anal abscess
  3. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  4. Scrotal abscess (pus in scrotum)
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Testicular abscess (pus in testes)
  7. Tooth abscess (pus formation in tooth)
  8. Cellulitis (infection under the skin)
  9. Cellulitis of male external genital organ (infection of male genitals soft tissue)
  10. Cellulitis staphylococcal (a type of bacteria originated skin soft tissue infection)

What are the common drug interactions of Phenylephrine Hydrochloride and Meloxicam, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Hand deformity
  2. Infection
  3. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  4. Drug hypersensitivity
  5. Drug ineffective
  6. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  7. Swelling
  8. Fibromyalgia (a long-term condition which causes pain all over the body)
  9. Dyspnoea (difficult or laboured respiration)
  10. Inflammation

50-59:

  1. Abdominal discomfort
  2. Abdominal pain upper
  3. Confusional state
  4. Contusion (a type of hematoma of tissue in which capillaries)
  5. Deep vein thrombosis postoperative (blood clot in a major vein that usually develops in the legs and/or pelvis after operation)
  6. Discomfort
  7. Dizziness
  8. Drug hypersensitivity
  9. Dry mouth
  10. Duodenal ulcer perforation (untreated ulcer can burn through the wall of the stomach)

60+:

n/a

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 36 people, 83.72%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 22 people, 51.16%
  3. Fibromyalgia (a long-term condition which causes pain all over the body): 13 people, 30.23%
  4. Stress And Anxiety: 13 people, 30.23%
  5. Psoriasis (immune-mediated disease that affects the skin): 11 people, 25.58%
  6. Inflammation: 8 people, 18.60%
  7. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder): 7 people, 16.28%
  8. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 6 people, 13.95%
  9. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 6 people, 13.95%
  10. Pain: 6 people, 13.95%

* Approximation only. Some reports may have incomplete information.

Do you take Phenylephrine hydrochloride and Meloxicam?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Phenylephrine hydrochloride and Meloxicam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Phenylephrine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Meloxicam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Phenylephrine hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Meloxicam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on phenylephrine hydrochloride and meloxicam (the active ingredients of Phenylephrine hydrochloride and Meloxicam, respectively), and Phenylephrine hydrochloride and Meloxicam (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: